 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||||||||
 |
 |
 |
|
|||||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|||
 |
|
|||||||||||||||
 |
|
|||||||||||||||
Titan Stock Quotes
Dec 15, 2008 - Titan Announces Reductions in Workforce |
 |
December 3, 2008 - Titan Announces Board Decision to Delist Common Stock |
|
December 2, 2008 - Titan Pharmaceuticals Announces Reduction in Force |
|
November 19, 2008 - Titan Presents Phase 3 Data for Probuphine® |
|
November 12, 2008 - Titan Pharmaceuticals Announces Data Presentations for Probuphine® at the 2008 International Society of Addiction Medicine Congress |
|
November 10, 2008 - Titan Pharmaceuticals Announces Third Quarter 2008 Financial Results |
|
November 5, 2008 - Titan Pharmaceuticals Updates Timing of Conference Call on Third Quarter 2008 Financial Results |
|
November 3, 2008 - Titan Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference |
|
October 30, 2008 - Titan Pharmaceuticals to Host Conference Call on Third Quarter 2008 Financial Results |
|
October 30, 2008 - Titan Pharmaceuticals Provides Update on Probuphine® Patent Application |
|
August 12, 2008 - Titan Pharmaceuticals Announces Second Quarter 2008 Financial Results |
|
August 7, 2008 - Titan Pharmaceuticals to Present at Canaccord Adams 28th Annual Global Growth Conference |
|
August 5, 2008 - Titan Pharmaceuticals to Host Conference Call on Second Quarter 2008 Financial Results |
|
July 28, 2008 - Titan Pharmaceuticals Announces Positive Results from Phase III Clinical Trial of Probuphine for the Treatment of Opioid Addiction |
|
July 28, 2008 - FDA Issues not Approvable Letter for Iloperidone to Vanda Pharmaceuticals |
|
July 2, 2008 - Titan Pharmaceuticals Announces Spheramine® Initial Phase IIb Results |
|
June 24, 2008 - Titan Pharmaceuticals Announces Spheramine® Presentations at 12th International Congress of Parkinson's Disease and Movement Disorders |
|
May 12, 2008 - Titan Pharmaceuticals Announces First Quarter 2008 Financial Results |
|
May 5, 2008 - Titan Pharmaceuticals to Host Conference Call on First Quarter 2008 Financial Results |
|
April 30, 2008 - Titan Pharmaceuticals, Inc. Executive Chairman, Dr. Louis R. Bucalo, Retires to Pursue Other Interests |
|
April 28, 2008 - Titan Pharmaceuticals Announces Spheramine® Presentation at 76th Annual American Association of Neurological Surgeons (AANS) Meeting |
|
March 12, 2008 - Titan Pharmaceuticals Announces Fourth Quarter and Year-End 2007 Financial Results |
|
March 7, 2008 - Titan Pharmaceuticals to Host Conference Call on Fourth Quarter 2007 and Year-End Financial Results |
|
Feburary 12, 2008 - Titan Pharmaceuticals to Present at Bio CEO & Investor Conference |
|